Grading criteria for disease severity by pemphigus disease area index

Tomoko Shimizu, Toru Takebayashi, Yuji Sato, Hironori Niizeki, Yumi Aoyama, Yasuo Kitajima, Keiji Iwatsuki, Takashi Hashimoto, Jun Yamagami, Victoria P. Werth, Masayuki Amagai, Akiko Tanikawa

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Pemphigus is a group of autoimmune blistering diseases that affect the skin and mucous membranes. A reliable and accurate disease severity tool to assess pemphigus severity is crucial for managing pemphigus and for clinical trials. The purpose of this study was to compare the pemphigus disease area index activity score (PDAI), the Japanese pemphigus disease severity score (JPDSS) and the physician's subjective impression, and also to find appropriate severity grading cut-offs for the PDAI. We also evaluated the correlation between PDAI activity score and the JPDSS. Thirty-seven pemphigus patients and 110 assessments were analyzed in this study. The optimal points of pemphigus disease severity score in PDAI were: mild (0-8), moderate (9-24) and severe (≥25). In mild or moderate cases, the JPDSS was well correlated with the PDAI, but in severe cases the JPDSS reached a plateau at a PDAI score of approximately 30. The PDAI evaluates disease severity more accurately than the JPDSS, particularly in severe cases. The PDAI is not only a useful tool to measure the extent of cutaneous lesions, but also an excellent scoring system for evaluating pemphigus disease severity.

Original languageEnglish
Pages (from-to)969-973
Number of pages5
JournalJournal of Dermatology
Volume41
Issue number11
DOIs
Publication statusPublished - 2014 Nov 1

Fingerprint

Pemphigus
Skin

Keywords

  • Clinical trial
  • Japanese pemphigus disease severity score
  • Outcome instrument
  • Pemphigus
  • Pemphigus disease area index
  • Severity index

ASJC Scopus subject areas

  • Dermatology

Cite this

Grading criteria for disease severity by pemphigus disease area index. / Shimizu, Tomoko; Takebayashi, Toru; Sato, Yuji; Niizeki, Hironori; Aoyama, Yumi; Kitajima, Yasuo; Iwatsuki, Keiji; Hashimoto, Takashi; Yamagami, Jun; Werth, Victoria P.; Amagai, Masayuki; Tanikawa, Akiko.

In: Journal of Dermatology, Vol. 41, No. 11, 01.11.2014, p. 969-973.

Research output: Contribution to journalArticle

Shimizu, T, Takebayashi, T, Sato, Y, Niizeki, H, Aoyama, Y, Kitajima, Y, Iwatsuki, K, Hashimoto, T, Yamagami, J, Werth, VP, Amagai, M & Tanikawa, A 2014, 'Grading criteria for disease severity by pemphigus disease area index', Journal of Dermatology, vol. 41, no. 11, pp. 969-973. https://doi.org/10.1111/1346-8138.12649
Shimizu, Tomoko ; Takebayashi, Toru ; Sato, Yuji ; Niizeki, Hironori ; Aoyama, Yumi ; Kitajima, Yasuo ; Iwatsuki, Keiji ; Hashimoto, Takashi ; Yamagami, Jun ; Werth, Victoria P. ; Amagai, Masayuki ; Tanikawa, Akiko. / Grading criteria for disease severity by pemphigus disease area index. In: Journal of Dermatology. 2014 ; Vol. 41, No. 11. pp. 969-973.
@article{085f9be241ae4c46ad36aec2d0395e3d,
title = "Grading criteria for disease severity by pemphigus disease area index",
abstract = "Pemphigus is a group of autoimmune blistering diseases that affect the skin and mucous membranes. A reliable and accurate disease severity tool to assess pemphigus severity is crucial for managing pemphigus and for clinical trials. The purpose of this study was to compare the pemphigus disease area index activity score (PDAI), the Japanese pemphigus disease severity score (JPDSS) and the physician's subjective impression, and also to find appropriate severity grading cut-offs for the PDAI. We also evaluated the correlation between PDAI activity score and the JPDSS. Thirty-seven pemphigus patients and 110 assessments were analyzed in this study. The optimal points of pemphigus disease severity score in PDAI were: mild (0-8), moderate (9-24) and severe (≥25). In mild or moderate cases, the JPDSS was well correlated with the PDAI, but in severe cases the JPDSS reached a plateau at a PDAI score of approximately 30. The PDAI evaluates disease severity more accurately than the JPDSS, particularly in severe cases. The PDAI is not only a useful tool to measure the extent of cutaneous lesions, but also an excellent scoring system for evaluating pemphigus disease severity.",
keywords = "Clinical trial, Japanese pemphigus disease severity score, Outcome instrument, Pemphigus, Pemphigus disease area index, Severity index",
author = "Tomoko Shimizu and Toru Takebayashi and Yuji Sato and Hironori Niizeki and Yumi Aoyama and Yasuo Kitajima and Keiji Iwatsuki and Takashi Hashimoto and Jun Yamagami and Werth, {Victoria P.} and Masayuki Amagai and Akiko Tanikawa",
year = "2014",
month = "11",
day = "1",
doi = "10.1111/1346-8138.12649",
language = "English",
volume = "41",
pages = "969--973",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Grading criteria for disease severity by pemphigus disease area index

AU - Shimizu, Tomoko

AU - Takebayashi, Toru

AU - Sato, Yuji

AU - Niizeki, Hironori

AU - Aoyama, Yumi

AU - Kitajima, Yasuo

AU - Iwatsuki, Keiji

AU - Hashimoto, Takashi

AU - Yamagami, Jun

AU - Werth, Victoria P.

AU - Amagai, Masayuki

AU - Tanikawa, Akiko

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Pemphigus is a group of autoimmune blistering diseases that affect the skin and mucous membranes. A reliable and accurate disease severity tool to assess pemphigus severity is crucial for managing pemphigus and for clinical trials. The purpose of this study was to compare the pemphigus disease area index activity score (PDAI), the Japanese pemphigus disease severity score (JPDSS) and the physician's subjective impression, and also to find appropriate severity grading cut-offs for the PDAI. We also evaluated the correlation between PDAI activity score and the JPDSS. Thirty-seven pemphigus patients and 110 assessments were analyzed in this study. The optimal points of pemphigus disease severity score in PDAI were: mild (0-8), moderate (9-24) and severe (≥25). In mild or moderate cases, the JPDSS was well correlated with the PDAI, but in severe cases the JPDSS reached a plateau at a PDAI score of approximately 30. The PDAI evaluates disease severity more accurately than the JPDSS, particularly in severe cases. The PDAI is not only a useful tool to measure the extent of cutaneous lesions, but also an excellent scoring system for evaluating pemphigus disease severity.

AB - Pemphigus is a group of autoimmune blistering diseases that affect the skin and mucous membranes. A reliable and accurate disease severity tool to assess pemphigus severity is crucial for managing pemphigus and for clinical trials. The purpose of this study was to compare the pemphigus disease area index activity score (PDAI), the Japanese pemphigus disease severity score (JPDSS) and the physician's subjective impression, and also to find appropriate severity grading cut-offs for the PDAI. We also evaluated the correlation between PDAI activity score and the JPDSS. Thirty-seven pemphigus patients and 110 assessments were analyzed in this study. The optimal points of pemphigus disease severity score in PDAI were: mild (0-8), moderate (9-24) and severe (≥25). In mild or moderate cases, the JPDSS was well correlated with the PDAI, but in severe cases the JPDSS reached a plateau at a PDAI score of approximately 30. The PDAI evaluates disease severity more accurately than the JPDSS, particularly in severe cases. The PDAI is not only a useful tool to measure the extent of cutaneous lesions, but also an excellent scoring system for evaluating pemphigus disease severity.

KW - Clinical trial

KW - Japanese pemphigus disease severity score

KW - Outcome instrument

KW - Pemphigus

KW - Pemphigus disease area index

KW - Severity index

UR - http://www.scopus.com/inward/record.url?scp=84913528898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84913528898&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.12649

DO - 10.1111/1346-8138.12649

M3 - Article

VL - 41

SP - 969

EP - 973

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

IS - 11

ER -